The benefits and risks of pulmonary artery catheterisation were assessed in 220 patients having cardiac or vascular surgery. Prior to induction of anaesthesia 20% of patients had pulmonary artery wedge pressure measurements which indicated the need for blood volume support, vasodilator therapy or modification of the anaesthetic induction technique. Of those patients for cardiac surgery, 38% had important changes before cardiopulmonary bypass requiring blood volume support or vasodilator therapy. These changes were not reflected by similar changes in the central venous pressure. The risks of the technique were minimal. Minor complications occurred in 25% of patients (transient arrhythmias) and more serious complications occurred in 3.6% of patients. There was no mortality or long-term sequelae. We conclude that the benefits of pulmonary artery catheterisation outweigh its risks in patients having major cardiac and vascular surgery.
A little more than a decade ago pulmonary artery catheterisation with a balloon-tipped catheter was described by Swan; I since that time it has become a very popular technique for the measurement of left heart filling pressures. Pace 2 described pulmonary artery catheterisation as one of the most important advances in the care of the critically ill, but it is an expensive technique with potentially serious or life-threatening complications. There are a number of papers assessing the value of the measurements in surgical patients 2 -11 and a number detailing the complications. 12-18 Two editorials l9 ,20 have called for an assessment of the risks weighed against the benefits of pulmonary artery catheterisation yet the question still remains unresolved.
We performed pulmonary artery catheterisation in 220 surgical patients in order to determine the frequency of intraoperative changes in the pulmonary artery wedge pressure (P A WP) requiring therapy, and to weigh these benefits against the incidence of catheterrelated complications.
MATERIALS AND METHODS
Pulmonary artery catheterisation was performed prior to induction of anaesthesia in 220 surgical patients who were to have a variety of cardiac and vascular operations ( Table 1) . Patients having coronary artery surgery were divided into two groups, those with normal left ventricular function and those with left ventricular dysfunction according to Kaplan's21 criteria based on history, examination and cardiac catheterisation. Each catheter was inserted by one of the authors or by an anaesthetic registrar under our supervision. The patient's premedication was supplemented in most cases with small doses of diazepam, and oxygen was administered via a face mask during the procedure. The patients had a peripheral intravenous infusion and radial artery cannula in situ and the ECG was monitored visually using an oscilloscope. The method of insertion was that described by Lappas 22 using a 7F triple lumen Swan-Ganz catheter (Edwards Laboratories) introduced via an 8F catheter sheath introducer system (Cordis). The operators wore sterile gown and gloves, the skin was prepared with chlorhexedine 0.50/0 or povidone-iodine (betadine) 10% and the region of insertion draped to allow for a large sterile area in order to prevent inadvertent contamination of the catheter. The right internal jugular vein was the preferred route of insertion, though other routes ( Table 2) were chosen if this route was contraindicated or technically difficult. Two methods were used to maintain a sterile section of catheter outside the circulation as repositioning by withdrawal or insertion of the catheter a few centimetres is often required. Two of us (KDC and CMD) used a plastic intracath sheath as described by Kopman,23 the other author (M1D) withdrew the introducer from the vein, leaving its end beneath the skin then filling the introducer with betadine ointment via its side arm. Each method maintained approximately 10 cm of sterile catheter outside the circulation. The pressures measured using the Swan-Ganz catheter were pulmonary artery pressure (P AP), pulmonary artery wedge pressure (P A WP), and central venous pressure (CVP) and these were measured at end expiration with Hewlett Packard transducers (model 1280) placed level with the patient's mid-axillary line. The pressure wave forms were displayed on an oscilloscope and the mean pressures recorded continuously on meters. The normal range of mean PAWP was taken as 5-12 mm Hg and mean CVP as 3-8 mm Hg. 22 The benefits of pulmonary artery catheterisation were assessed during two periods. Firstly P A WP was recorded before induction of anaesthesia. Low pressures « 5 mm Hg) were treated with intravenous colloid infusion to increase the pressure into the normal range before induction of anaesthesia. High pressures (::> 18 mm Hg) were treated by modifying the induction sequence using a diazepam -phenoperidine -nitrous oxide induction rather than sodium thiopentone or occasionally intravenous nitroglycerin was given to lower the pressure towards the normal range. The second period of assessment was prior to cardiopulmonary bypass in the case of cardiac operation and throughout the operation in the case of vascular operations. This period of assessment was chosen because left heart filling pressures can best be measured by pulmonary artery catheterisation prior to cardiopulmonary bypass whereas after cardiopulmonary bypass left atrial catheterisation is a suitable alternative method. Pressures below 5 mm Hg were considered an indication for blood volume support and those above 18 mm Hg were generally treated with intravenous nitroglycerin. These high pressures were treated because Forrester 24 has shown that they can be associated with an increased incidence of radiological pulmonary congestion and the increased preload may be associated with myocardial ischaemia.
Complications of the route of insertion and those immediately associated with catheter insertion were noted at the time of placing the catheter. Late complications were noted by reassessing the patients clinically until the catheter was removed. The pulmonary artery pressure was monitored continuously in the postoperative period in order to detect and correct permanent wedging early. All patients had postoperative chest x-rays and the duratio!1 of catheterisation was recorded to the nearest hour. RESULTS 
Pre-induction:
Before induction of anaesthesia the PA WP was normal (5-12 mm Hg) in 109 patients, high ( > 12 mm Hg) in 73 patients and low ( < 5 mm Hg) in 38. However, of the patients who had raised P A WP, 52 had pressures greater than 18 mm Hg which was considered an indication for vasodilator therapy or a modification of the anaesthetic induction sequence. Therefore in 410,10 of patients the preinduction P A WP measurement resulted in some therapeutic action. Of these half had similar changes in the CVP, thus the pulmonary artery catheter was of benefit in 45 patients (20%). Figures 1 and 2 show the distribution of these changes in the different groups of patients. Abnormal measurements were most frequently found in patients with mitral or double valve disease, but in the case of mitral stenosis the P A WP does not represent left ventricular filling pressure; however in these patients the ability to measure pulmonary artery pressure is 
Pre-cardiopulmonary bypass:
In 120 (62%) of the 195 patients who underwent cardiopulmonary bypass there were changes in P A WP for which specific treatment was employed. In 91 patients the PA WP rose to high levels and was treated with nitroglycerin and in the remaining 29 patients blood volume replacement was instituted because the P A WP fell below 5 mm Hg. In one patient catheter malfunction occurred and it was of no assistance to patient care. The distribution of these changes in the different groups of patients is shown in Figures 3 and 4 . Again changes were most common in patients having valve replacement, among whom 47 patients (89%) had P A WP changes requiring therapy. In the coronary artery surgery patients, 45 (55070) with left ventricular dysfunction and 24 (43070) with normal left ventricular function had important changes. The CVP failed to correlate with these PA WP changes in 62070 of patients. Therefore in the pre-bypass period the pulmonary artery catheter was of benefit in 74 patients (38070). Figure 5 shows an example where the P A WP or pulmonary artery end diastolic pressure rises without changes in the other cardiovascular parameters.
Vascular surgery:
In these 22 patients the P A WP measurement was of value for the assessment of blood volume status in 11 patients, and 8 patients had substantial rises associated with aortic cross clamping. In these patients the CVP was not measured so that we were unable to assess correlation between CVP and P A WP. 
Complications:
The complications that occurred are summarised in Table 3 . The carotid artery punctures, which occurred with the 160 needle or intravenous cannula, did not result in any neurological sequelae, but one patient developed a large neck haematoma which resolved spontaneously. Multiple ventricular ectopic beats occurred in 55 patients as the catheter was passed through the right ventricle and one patient developed a short episode of supraventricular tachycardia. Two of these patients received intravenous lignocaine while the rest responded to removal of the catheter from the right ventricle. Septicaemia was confirmed by blood culture in four patients, the source of infection being the wound in one patient and not identified in the other three. One patient had a probable pulmonary infarct diagnosed by chest x-ray but had nO respiratory symptoms. The low incidence of delayed complications was probably a reflection of the relatively short duration of catheterisation (29.7 hours, S.D. 18.3).
There were five additional patients in whom pulmonary artery catheterisation was attempted but failed. In two patients this was because internal jugular vein puncture was contraindicated and alternate routes of insertion failed. In one patient we were unable to cannulate the internal jugular vein and in the two other patients we were unable to thread the catheter into the pulmonary artery.
DISCUSSION
The indications for pulmonary artery catheterisation are still being defined. Many authors state that patients having major surgery who have significant cardiac and respiratory disease 6 ,12 or serious illness 4 should have a pulmonary artery catheter inserted, as these are patients in whom the CVP has been shown to be an unreliable guide to left ventricular function and blood volume replacement. Patients with coronary artery disease are a difficult group because it is a common condition in patients having major surgery. Mangano lO was able to define only by cardiac catheterisation the indications for pulmonary artery catheterisation in patients having coronary artery surgery. He found that patients who had an ejection fraction of less than 0.4 or with left ventricular dyssynergy had poor correlation of changes in PA WP and CVP. This information is not helpful, however, in patients having non-cardiac surgery as cardiac catheterisation information is usually not available. Our results confirm the value of the technique in patients with valvular heart disease but in coronary artery disease it is very difficult to clinically predict in which patients this form of monitoring is of most value.
The potential hazards of the procedure should not be underestimated. It is a procedure that should only be used by experienced operators with good assistance and good monitoring equipment. Carotid artery puncture (3.6070) was the commonest problem specifically related to the route of insertion used in our series. It can result in a sizeable neck haematoma when patients are subsequently heparinised unless local arterial compression is applied for five minutes. 12
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Delayed complications can be lifethreatening and are only limited by careful attention to detail in the management of the catheter after it has been inserted. Infection is a potentially serious problem as repositioning of the catheter may be necessary in about 25% of patients. 23 Michel et al. 14 reviewed the problem of infection of pulmonary artery catheters in critically ill patients and found catheter contamination or colonisation in 19% of patients, but were unable to identify definite catheter-related sepsis. Elliott et al. 13 however found catheter contamination or colonisation in 35% of patients and a 2% incidence of catheter-related septicaemia. Our incidence of possibly catheter-related septicaemia of 1.4% (3/220) is low, particularly when staphylococcus aureus colonisation was reemerging as a problem in our surgical patients. This low incidence may be related to the methods we use to maintain the sterility of a portion of the extravascular catheter.
The list of less common complications of pulmonary artery catheters is long. These incl ude pulmonary infarction or embolisation,12 pulmonary artery rupture, 15 heart valve vegetations,13 and intracardiac knotting. We consider that the incidence of these complications is minimised by the use of a careful insertion technique by an experienced operator and good postoperative management.
Our study shows that in patients having cardiac and major vascular surgery, pulmonary artery catheterisation detects important changes of P A WP in 20% of patients prior to induction of anaesthesia and in 38% of cardiac patients before cardiopulmonary bypass. Minor complications were relatively frequent (25% arrhythmia) but major complications uncommon. We conclude that the benefits of pulmonary artery catheterisation outweigh the risks. However, it is difficult to go so far as to say that these benefits reduce the mortality and morbidity of patients having this form of surgery. In the literature two studies 25 ,26 claim a reduction in mortality by using haemodynamic information obtained from pulmonary artery catheterisation. Moore 25 reduced the mortality of patients with left main coronary artery stenosis from 20070 to 3.5% and attributed this largely to improvements in monitoring. Whittemore et al. 26 reported only one death in 110 patients having repair of non-ruptured infra-renal aortic aneurysms and again attributed this low mortality to improved management based on data provided by pulmonary artery catheterisation. In our patients having coronary artery surgery there were two deaths in 138 patients. Improved monitoring, including pulmonary artery wedge pressure, contributed to the low mortality.
